Monitoring antimalarial safety and tolerability in clinical trials: A case study from Uganda

BACKGROUND: New antimalarial regimens, including artemisinin-based combination therapies (ACTs), have been adopted widely as first-line treatment for uncomplicated malaria. Although these drugs appear to be safe and well-tolerated, experience with their use in Africa is limited and continued assessm...

Descripción completa

Detalles Bibliográficos
Autores principales: Staedke, Sarah G, Jagannathan, Prasanna, Yeka, Adoke, Bukirwa, Hasifa, Banek, Kristin, Maiteki-Sebuguzi, Catherine, Clark, Tamara D, Nzarubara, Bridget, Njama-Meya, Denise, Mpimbaza, Arthur, Rosenthal, Philip J, Kamya, Moses R, Wabwire-Mangen, Fred, Dorsey, Grant, Talisuna, Ambrose O
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Case Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2464601/
https://www.ncbi.nlm.nih.gov/pubmed/18547416
http://dx.doi.org/10.1186/1475-2875-7-107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2464601/
https://www.ncbi.nlm.nih.gov/pubmed/18547416
http://dx.doi.org/10.1186/1475-2875-7-107

Ejemplares similares